Metaplanet
3350
Mitsubishi Heavy Industries
7011
Nippon Telegraph & Telephone
9432
4
Kioxia Holdings
285A
5
Sanrio
8136
JP Stock MarketDetailed Quotes
219A Heartseed
- 1867
- +36+1.97%
20min DelayNot Open Feb 18 15:30 JST
41.49BMarket Cap-37.77P/E (Static)
1996High1800Low1.80MVolume1860Open1831Pre Close3.42BTurnover388052wk High22.88%Turnover Ratio22.23MShares90152wk Low-49.43EPS TTM14.67BFloat Cap3880Historical HighLossP/E (Static)7.86MShs Float901Historical Low-49.43EPS LYR10.71%Amplitude--Dividend TTM6.27P/B100Lot Size--Div YieldTTM
Heartseed News
Heartseed: Notice Regarding the Completion of the enrollment in Phase 1/2 Clinical Trial (LAPiS Study)
Heartseed: Notice of completion of HS-001 LAPIS test administration
Heartseed: Matters relating to business plans and growth potential
Heartseed: Articles of Incorporation 2025/01/24
Heartseed: Notice regarding changes in the fiscal period (the last day of the fiscal year) and partial changes to the Articles of Incorporation
Heartseed: [Delayed]Financial Results for the Fiscal Year Ended October 31, 2024 (Under Japan GAAP)(Non-consolidated)
Heartseed: Notice Regarding the LAPiS Study Progress
Heartseed: Notice regarding the progress of the HS-001 LAPIS test
Heartseed: Notice Regarding the Revisions of Full-Year Financial Results Forecast for the Fiscal Year Ending October 31, 2024
Heartseed: Notice of completion of safety evaluation committee review on administration of HS-001 LAPIS test high dose group first case
Heartseed: [Delayed] Financial Results for the Nine Months Ended July 31, 2024 (Under Japan GAAP)(Non-consolidated)
Heartseed: Independent Company Executives Declaration
Heartseed: Articles of Incorporation 2024/04/17
Heartseed: Heartseed announced a positive recommendation from the safety monitoring committee regarding dose escalation in Phase 1/2 clinical trials administered with HS-001.
Heartseed: In the HS-001 LAPiS trial, the Safety Evaluation Committee recommended the start of administration in the high-dose group.
Heartseed: Matters related to business plans and growth potential.
Heartseed: Announcements of individual stocks regarding our financial information etc. due to our listing on the Tokyo Stock Exchange Growth Market.
Heartseed Inc.: Confirmation letter regarding the appropriateness of securities reports for listing application.
Heartseed Inc.: Quarterly report for IPO application (Q2)
Heartseed Inc.: Quarterly report for initial public offering (Q1)